State University of New York at Buffalo

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1846-05-11

Employees: 1K

Market Cap: -

Website: http://www.buffalo.edu

Clinical Trials

Anomia Treatment Predictors

Not Applicable

Active, not recruiting

Conditions: Anomia (Word-Finding Impairment)
Aphasia

Interventions: Behavioral: Anomia Treatment

First Posted Date: 2024-10-01

Last Posted Date: 2024-12-10

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 2

Registration Number: NCT06619756

Locations: 🇺🇸
UB Audiology and Speech-Language Pathology Clinic, Buffalo, New York, United States

Work Design Interventions for Heat Resilience

Not Applicable

Not yet recruiting

Conditions: Hyperthermia
Fatigue; Heat
Work-Related Condition

Interventions: Behavioral: Self-paced work
Behavioral: Reduced-pace work
Behavioral: Increased-pace work
Behavioral: Additional rest breaks

First Posted Date: 2024-09-19

Last Posted Date: 2024-09-19

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 16

Registration Number: NCT06599788

Lithium for Parkinson's: an Extension Trial

Phase 1

Conditions: Parkinson Disease

Interventions: Dietary Supplement: Lithium aspartate

First Posted Date: 2024-09-19

Last Posted Date: 2024-10-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 35

Registration Number: NCT06592014

Locations: 🇺🇸
UBMD Neurology, Williamsville, New York, United States

Project ASTHMA - Aligning With Schools To Help Manage Asthma and Decrease Health Inequities

Not Applicable

Recruiting

Conditions: Asthma in Children
Directly Observed Therapy

Interventions: Other: APP assessment and management of asthma

First Posted Date: 2024-08-06

Last Posted Date: 2024-11-21

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 400

Registration Number: NCT06539312

Locations: 🇺🇸
University at Buffalo, Department of Pediatrics, Buffalo, New York, United States

Sevoflurane Concentrations in Children

Recruiting

Conditions: Sevoflurane
Age
Anesthetic

Interventions: Drug: The case intervention is the sevoflurane concentrations with the Drager Apollo workstation

First Posted Date: 2024-07-19

Last Posted Date: 2024-10-26

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 28

Registration Number: NCT06510803

Locations: 🇺🇸
John R. Oishei Children's Hospital, Buffalo, New York, United States

PICU-related Sleep and Circadian Dysregulation Pilot Study

Not Applicable

Not yet recruiting

Conditions: Sleep Disturbance
Children, Only
Circadian Dysrhythmia
Critical Illness

Interventions: Other: Daytime light exposure
Other: Daytime restricted feeding

First Posted Date: 2024-07-17

Last Posted Date: 2024-10-09

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 30

Registration Number: NCT06505447

Facilitated Telemedicine in the Catholic Health System

Not yet recruiting

Conditions: HCV

First Posted Date: 2024-07-03

Last Posted Date: 2024-11-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 200

Registration Number: NCT06483451

Predicting Responses to Exhausting, Prolonged, and Repeated Exercise Demands (PREPARED) for Heat

Not Applicable

Recruiting

Conditions: Fatigue; Heat
Hyperthermia

Interventions: Other: 30/30 work/rest cycle
Other: 30/20 work/rest cycle
Other: 40/30 work/rest cycle
Other: 20/12 work/rest cycle

First Posted Date: 2024-06-26

Last Posted Date: 2024-12-20

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 24

Registration Number: NCT06475339

Locations: 🇺🇸
Center for Research and Education in Special Environments, Buffalo, New York, United States

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

Phase 2

Not yet recruiting

Conditions: Multiple Sclerosis

Interventions: Drug: Placebo
Drug: metformin

First Posted Date: 2024-06-18

Last Posted Date: 2024-10-28

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 30

Registration Number: NCT06463743

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Not Applicable

Active, not recruiting

Conditions: Intracranial Aneurysms

Interventions: Device: Pipeline™ Flex Embolization Device with Shield Technology™

First Posted Date: 2024-05-13

Last Posted Date: 2024-10-08

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 10

Registration Number: NCT06411418

Locations: 🇺🇸
University at Buffalo Neurosurgery, Buffalo, New York, United States

Home Terms & Conditions Privacy Policy